| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/30/2010 | EP2200989A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 06/30/2010 | EP2200985A1 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 06/30/2010 | EP2200982A1 Piperidine derivatives as nk3 receptor antagonists |
| 06/30/2010 | EP2200609A1 Compounds for the treatment of metabolic disorders |
| 06/30/2010 | EP2200436A1 Substituted pyrimidinyl-amines as protein kinase inhibitors |
| 06/30/2010 | EP2089381B1 Indoles which act as via receptor antagonists |
| 06/30/2010 | EP2021336B1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/30/2010 | EP1943216B1 Prolinamide derivatives as sodium channel modulators |
| 06/30/2010 | EP1841757B1 Heteroaromatic quinoline compounds and their use as pde10 inhibitors |
| 06/30/2010 | EP1673349B1 Benzimidazole derivatives: preparation and pharmaceutical applications |
| 06/30/2010 | EP1542970B1 Pyrrolidone derivatives as maob inhibitors |
| 06/30/2010 | EP1476435B1 Novel pyridin- and pyrimidin-derivatives |
| 06/30/2010 | EP1368323B1 Pyrimidine matrix metalloproteinase inhibitors |
| 06/30/2010 | EP1330436B1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3-3 receptor antagonists |
| 06/30/2010 | EP1278735B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 06/30/2010 | CN101765597A Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase |
| 06/30/2010 | CN101765595A Process for preparing voriconazole |
| 06/30/2010 | CN101765591A Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 06/30/2010 | CN101765430A New pyrazol derivatives |
| 06/30/2010 | CN101765371A pesticides and uses thereof |
| 06/30/2010 | CN101759684A Diaryl pyrimidine derivative, preparation method and use thereof |
| 06/30/2010 | CN101759683A Preparation method of hydrindene amide compound, medical composition comprising hydrindene amide compound and application thereof as protein kinase inhibitor |
| 06/30/2010 | CN101759645A P38 inhibitors and methods of use thereof |
| 06/29/2010 | US7745639 Dihydropyrazoles; anticarcinogenic agents can be synergistically combined with one or more active ingredients; side effect reduction |
| 06/29/2010 | US7745638 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide |
| 06/29/2010 | US7745630 Triazolyl piperidine arginine vasopressin receptor modulators |
| 06/29/2010 | US7745625 Phosphate prodrugs; treating HIV infection; 1-(phosphomethyl)-3-(2-(4-benzoylpiperazin-1-yl)-1,2-dioxoethyl)-4,7-dimethoxy-1H-pyrrolo(2,3-c)pyridine for example; improved water solubility, bioavailability for oral administration |
| 06/29/2010 | US7745623 Cyclic amide derivative, and its production and use |
| 06/29/2010 | US7745479 1,5-substituted indol-2-yl amide derivatives |
| 06/29/2010 | US7745467 For therapy of pain, inflammation, urological disorders, gynecological disorders, gastrointestinal disorders, respiratory disorders, psoriasis, pruritus, dermal, ocular or mucous irritation, herpes or zona, diabetes, depression |
| 06/29/2010 | US7745466 Magnesium salt of S-omeprazole trihydrate of crystal form and another drug such as NSAID, antibiotic, antacid, alginates or prokinetic agents; gastric acid secretion inhibitor, and is useful as an antiulcer agent |
| 06/29/2010 | US7745462 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors |
| 06/29/2010 | US7745460 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives |
| 06/29/2010 | US7745454 Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| 06/29/2010 | US7745453 Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase |
| 06/29/2010 | US7745444 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 06/29/2010 | US7745443 antagonists of the interaction between the plasma protein von Willebrand factor (vWF) and the blood platelet receptor glycoprotein Ib-IX-V complex, exhibit anticoagulant effect and are suitable for the therapy and prophylaxis of cardiovascular disorders |
| 06/29/2010 | US7745442 Methods of reducing risk of infection from pathogens |
| 06/29/2010 | US7745437 Compounds and compositions as protein kinase inhibitors |
| 06/29/2010 | US7745436 Disalt inhibitors of IL-12 production |
| 06/29/2010 | US7745021 Light sources comprising organic light emmiters between electrodes, used in displaying, electrophotography, recording, exposure, signs or optical communications; brightness; efficiency; durability; iridium complex |
| 06/29/2010 | US7744838 Functionalized ionic liquids, and methods of use thereof |
| 06/29/2010 | CA2557856C 3-'4-heterocyclyl-1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 06/29/2010 | CA2542007C Protein tyrosine kinase inhibitors |
| 06/29/2010 | CA2539541C Isoquinolinone potassium channel inhibitors |
| 06/29/2010 | CA2474246C Alkylammonium salts of omeprazole and esomeprazole |
| 06/29/2010 | CA2453117C Oral dosage forms comprising a benzimidazole and buffer |
| 06/29/2010 | CA2387746C Methods for stabilizing benzimidazole-based compounds |
| 06/29/2010 | CA2345985C Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives,processes for their preparation, pharmaceuticals comprising these compounds and their use |
| 06/24/2010 | WO2010071837A1 Pyrazine derivatives useful as inhibitors of atr kinase |
| 06/24/2010 | WO2010071575A1 Quaternary piperidine derivatives and uses thereof |
| 06/24/2010 | WO2010071559A1 Processes for the manufacture of 3-{4-methyl-5- [ (ir) -1- (2- (3-methylphenyl) -2h-tetrazol-5-yl) -ethoxy] -4h- [1,2, 4] triazol-3-yl} -pyridine, 4-methyl-3-methylthio-5- (3- pyridyl)-l,2,4-triazole, and (ir) -1- [2- (3-methylphenyl) -2h- tetrazol-5-yl] ethanol |
| 06/24/2010 | WO2010070032A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
| 06/24/2010 | WO2010070022A1 Novel compounds |
| 06/24/2010 | WO2010069966A1 Substituted indazole derivatives active as kinase inhibitors |
| 06/24/2010 | WO2010069879A1 Pyrrole derivatives for use as plant growth regulators |
| 06/24/2010 | WO2010069877A1 Isothiazole and pyrazole derivatives for use as plant growth regulators |
| 06/24/2010 | WO2010069833A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation |
| 06/24/2010 | WO2010069504A1 (3-oxo)pyridin-4-ylurea derivatives as pde4 inhibitors |
| 06/24/2010 | WO2010069502A2 Tetrazole substituted anthranilic acid amides as pesticides |
| 06/24/2010 | WO2010069266A1 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof |
| 06/24/2010 | WO2010069147A1 Dihydropyrimidine derivatives, compositions thereof and their use |
| 06/24/2010 | WO2010069069A1 Cathepsin b inhibitors |
| 06/24/2010 | WO2010039885A3 Crystalline forms of dexlansoprazole |
| 06/24/2010 | WO2010038086A3 P38 map kinase inhibitors |
| 06/24/2010 | WO2010038085A3 P38 map kinase inhibitors |
| 06/24/2010 | WO2010019832A3 Amide-extended crosslinking compounds and methods for use thereof |
| 06/24/2010 | US20100160639 Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds |
| 06/24/2010 | US20100160637 Method for the production of 4-formylaminopiperidine derivatives |
| 06/24/2010 | US20100160629 Cyclic amide derivative, and its production and use |
| 06/24/2010 | US20100160384 Dihydropyridone amides as p2x7 modulators |
| 06/24/2010 | US20100160383 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation |
| 06/24/2010 | US20100160381 RAF Inhibitors for the Treatment of Thyroid Cancer |
| 06/24/2010 | US20100160380 Therapeutic Salt Compositions and Methods |
| 06/24/2010 | US20100160377 Derivatives of pyrazole 3,5-carboxylates, their preparation and their application in therapeutics |
| 06/24/2010 | US20100160373 Dihydropyridone amides as p2x7 modulators |
| 06/24/2010 | US20100160360 Jnk modulators |
| 06/24/2010 | US20100160359 Modulators of Metabolism and the Treatment of Disorders Related Thereto |
| 06/24/2010 | US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160336 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors |
| 06/24/2010 | US20100160331 Novel carbamoyloxy arylalkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
| 06/24/2010 | US20100160328 New compounds useful for dpp-iv enzyme inhibition |
| 06/24/2010 | US20100160324 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
| 06/24/2010 | US20100160323 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 06/24/2010 | US20100160322 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 06/24/2010 | US20100160321 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase |
| 06/24/2010 | US20100160320 C5aR ANTAGONISTS |
| 06/24/2010 | US20100160319 Histamine h3 receptor agents, preparation and therapeutic uses |
| 06/24/2010 | US20100160318 3-Pyrrolo[b]Cyclohexylene-2-Dihydroindolinone Derivatives and Uses Thereof |
| 06/24/2010 | US20100160313 Discovery of novel anticancer compounds based on conformational sampling of quinoxalinhydrazide pharmacophore |
| 06/24/2010 | US20100160312 Substituted Pyridone Compounds and Methods of Use |
| 06/24/2010 | US20100160307 Method for controlling particular insect pests by applying anthranilamide compounds |
| 06/24/2010 | US20100160306 Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists |
| 06/24/2010 | US20100160305 3, 4, 5 - Substituted Piperidine Compounds |
| 06/24/2010 | US20100160297 Compounds for pim kinase inhibition and for treating malignancy |
| 06/24/2010 | US20100160292 Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors |
| 06/24/2010 | US20100160287 Compounds useful as inhibitors of janus kinases |
| 06/24/2010 | US20100160281 Monocarbams |
| 06/24/2010 | US20100160280 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors |